Literature DB >> 22077451

Stereotactic radiosurgery for arteriovenous malformations, Part 4: management of basal ganglia and thalamus arteriovenous malformations.

Hideyuki Kano1, Douglas Kondziolka, John C Flickinger, Huai-che Yang, Thomas J Flannery, Ajay Niranjan, Josef Novotny, L Dade Lunsford.   

Abstract

OBJECT: The authors conducted a study to define the long-term outcomes and risks of stereotactic radiosurgery (SRS) for arteriovenous malformations (AVMs) of the basal ganglia and thalamus.
METHODS: Between 1987 and 2006, the authors performed Gamma Knife surgery in 996 patients with brain AVMs; 56 patients had AVMs of the basal ganglia and 77 had AVMs of the thalamus. In this series, 113 (85%) of 133 patients had a prior hemorrhage. The median target volume was 2.7 cm(3) (range 0.1-20.7 cm(3)) and the median margin dose was 20 Gy (range 15-25 Gy).
RESULTS: Obliteration of the AVM eventually was documented on MR imaging in 78 patients and on angiography in 63 patients in a median follow-up period of 61 months (range 2-265 months). The actuarial rates documenting total obliteration after radiosurgery were 57%, 70%, 72%, and 72% at 3, 4, 5, and 10 years, respectively. Factors associated with a higher rate of AVM obliteration included AVMs located in the basal ganglia, a smaller target volume, a smaller maximum diameter, and a higher margin dose. Fifteen (11%) of 133 patients suffered a hemorrhage during the latency period and 7 patients died. The rate of post-SRS AVM hemorrhage was 4.5%, 6.2%, 9.0%, 11.2%, and 15.4% at 1, 2, 3, 5, and 10 years, respectively. The overall annual hemorrhage rate was 4.7%. When 5 patients with 7 hemorrhages occurring earlier than 6 months after SRS were removed from this analysis, the annual hemorrhage rate decreased to 2.7%. Larger volume AVMs had a higher risk of hemorrhage after SRS. Permanent neurological deficits due to adverse radiation effects (AREs) developed in 6 patients (4.5%), and in 1 patient a delayed cyst developed 56 months after SRS. No patient died of AREs. Factors associated with a higher risk of symptomatic AREs were larger target volume, larger maximum diameter, lower margin dose, and a higher Pollock-Flickinger score.
CONCLUSIONS: Stereotactic radiosurgery is a gradually effective and relatively safe management option for deep-seated AVMs in the basal ganglia and thalamus. Although hemorrhage after obliteration did not occur in the present series, patients remain at risk during the latency interval between SRS and obliteration. The best candidates for SRS are patients with smaller volume AVMs located in the basal ganglia.

Entities:  

Mesh:

Year:  2011        PMID: 22077451     DOI: 10.3171/2011.9.JNS11175

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  14 in total

1.  Deep arteriovenous malformations in the basal ganglia, thalamus, and insula: multimodality management, patient selection, and results.

Authors:  Matthew B Potts; Arman Jahangiri; Maxwell Jen; Penny K Sneed; Michael W McDermott; Nalin Gupta; Steven W Hetts; William L Young; Michael T Lawton
Journal:  World Neurosurg       Date:  2014-03-19       Impact factor: 2.104

2.  Deep arteriovenous malformations in the Basal Ganglia, thalamus, and insula: microsurgical management, techniques, and results.

Authors:  Matthew B Potts; William L Young; Michael T Lawton
Journal:  Neurosurgery       Date:  2013-09       Impact factor: 4.654

3.  Ruptured brain arteriovenous malformations associated with aneurysms: safety and efficacy of selective embolization in the acute phase of hemorrhage.

Authors:  Francesco Signorelli; Benjamin Gory; Isabelle Pelissou-Guyotat; Jacques Guyotat; Roberto Riva; Frédéric Dailler; Francis Turjman
Journal:  Neuroradiology       Date:  2014-06-28       Impact factor: 2.804

4.  Microsurgical Treatment of Deep and Eloquent AVMs.

Authors:  Phillip Cem Cezayirli; Hatice Türe; Uğur Türe
Journal:  Adv Tech Stand Neurosurg       Date:  2022

5.  Dynamic CT angiography for cyberknife radiosurgery planning of intracranial arteriovenous malformations: a technical/feasibility report.

Authors:  Anoop Haridass; Jillian Maclean; Santanu Chakraborty; John Sinclair; Janos Szanto; Daniela Iancu; Shawn Malone
Journal:  Radiol Oncol       Date:  2015-03-25       Impact factor: 2.991

6.  Using a Machine Learning Approach to Predict Outcomes after Radiosurgery for Cerebral Arteriovenous Malformations.

Authors:  Eric Karl Oermann; Alex Rubinsteyn; Dale Ding; Justin Mascitelli; Robert M Starke; Joshua B Bederson; Hideyuki Kano; L Dade Lunsford; Jason P Sheehan; Jeffrey Hammerbacher; Douglas Kondziolka
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

7.  Stereotactic radiosurgery for thalamus arteriovenous malformations.

Authors:  Mohameth Faye; Moussa Diallo; Manal Sghiouar; Elhadji Cheikh Ndiaye Sy; Pierre Yves Borius; Jean-Marie Régis
Journal:  J Radiosurg SBRT       Date:  2020

Review 8.  Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas.

Authors:  Mingze Wang; Yuming Jiao; Chaofan Zeng; Chaoqi Zhang; Qiheng He; Yi Yang; Wenjun Tu; Hancheng Qiu; Huaizhang Shi; Dong Zhang; Dezhi Kang; Shuo Wang; A-Li Liu; Weijian Jiang; Yong Cao; Jizong Zhao
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

9.  Hypofractionated stereotactic radiosurgery in a large bilateral thalamic and Basal Ganglia arteriovenous malformation.

Authors:  Janet Lee; Tomoko Tanaka; Steven Westgate; Ashish Nanda; Marshall Cress; N Scott Litofsky
Journal:  Case Rep Neurol Med       Date:  2013-11-06

10.  Surgical removal of an arteriovenous malformation in the anterior perforated substance in a pregnant woman.

Authors:  Daisuke Wakui; Hidemichi Ito; Hiroshi Takasuna; Hidetaka Onodera; Kotaro Oshio; Yuichiro Tanaka
Journal:  Surg Neurol Int       Date:  2018-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.